➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
McKinsey
AstraZeneca
Boehringer Ingelheim
Baxter

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CALCIJEX

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for CALCIJEX

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis Terminated Abbott Phase 4 2003-04-01 To evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney disease on hemodialysis as measured by time to death.
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium Completed Abbott Phase 4 2004-09-01 A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for CALCIJEX

Condition Name

Condition Name for CALCIJEX
Intervention Trials
Secondary Hyperparathyroidism 1
End-Stage Kidney Disease 1
Chronic Kidney Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for CALCIJEX
Intervention Trials
Renal Insufficiency, Chronic 2
Kidney Diseases 2
Hyperparathyroidism, Secondary 1
Hyperparathyroidism 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for CALCIJEX

Trials by Country

Trials by Country for CALCIJEX
Location Trials
United States 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for CALCIJEX
Location Trials
Nebraska 1
Louisiana 1
California 1
Colorado 1
Connecticut 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for CALCIJEX

Clinical Trial Phase

Clinical Trial Phase for CALCIJEX
Clinical Trial Phase Trials
Phase 4 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for CALCIJEX
Clinical Trial Phase Trials
Completed 1
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for CALCIJEX

Sponsor Name

Sponsor Name for CALCIJEX
Sponsor Trials
Abbott 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for CALCIJEX
Sponsor Trials
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Medtronic
Merck
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.